Vaishali Pharma Ltd.

130.00 -1.60 ▼-1.2%

08 June 2023, 03:57:41 PM
Volume: 55,225

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.vaishalipharma.com
Market Cap 137.75 Cr.
Enterprise Value(EV) 150.43 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 6.23 Trailing Twelve Months Ending 2023-03
Price-Earning Ratio (PE) 20.86 Trailing Twelve Months Ending 2023-03
Industry PE 33.65 Trailing Twelve Months Ending 2023-03
Book Value / Share 38.30 Trailing Twelve Months Ending 2023-03
Price to Book Value 3.39 Calculated using Price: 130.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 1.06 Cr. 10,596,213 Shares
FaceValue 10
About Vaishali Pharma Ltd.
The company is a pharmaceutical company, dealing in pharmaceutical formulations, APIs, surgical products, veterinary supplements. It is operating both in domestic and export markets. In domestic markets, it is majorly into trading of APIs whereas in export markets, it is into trading and marketing of APIs, formulations, surgical products and others. For its export markets, the company gets the formulations manufactured by third parties whose facilities are approved and certified by the respective countries for developing the respective products. At present, it has applied for 186 registrations in 13 countries for some of its products, out of which it has successfully received 71 approvals from 7 countries and is in process of obtaining remaining approvals, which will give boost to its export business operations.

Vaishali Pharma Ltd. Delivery

Delivered Qty
Traded Qty

Vaishali Pharma Ltd. Performance

1 Day
-1.22%
1 Week
-4.52%
1 Month
-10.50%
3 Month
-20.44%
6 Month
+6.17%
1 Year
+66.13%
2 Year
+256.16%
5 Year
+246.67%
10 Year

Vaishali Pharma Ltd. Fundamental Ratios

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 10.28 5.12 -0.94 19.80 6.49 3.40 0.15 4.78 16.50
Return on Capital Employed (%) 19.23 14.04 12.80 16.18 12.75 9.80 6.89 10.33 18.87
Return on Assets (%) 0.59 0.33 -0.06 1.51 1.47 1.08 0.05 1.38 4.81

Vaishali Pharma Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03* Rs. Cr.
Shh. Funds 3 3 3 4 21 21 21 22 26 41
Non Curr. Liab. 3 8 5 3 3 5 4 4 3 6
Curr. Liab. 47 34 42 37 41 42 40 59 52 32
Minority Int.
Equity & Liab. 53 46 49 45 64 69 66 86 81 79
Non Curr. Assets 2 2 2 5 5 6 5 5 5 6
Curr. Assets 52 44 47 40 59 63 61 81 76 73
Misc. Exp. not W/O
Total Assets 53 46 49 45 64 69 66 86 81 79

Vaishali Pharma Ltd. Profit and Loss

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. TTM
Net Sales 121 95 67 64 68 75 60 54 76 70
Other Income 1 4 3 1 2 2 2 2 2 2
Total Income 122 99 70 65 69 77 62 56 78 72
Total Expenditure -118 -95 -66 -61 -65 -73 -59 -51 -69 -61
PBIDT 3 4 4 4 4 4 3 4 9 11
Interest -3 -3 -3 -3 -3 -3 -3 -3 -2 -2
Depreciation 0 0 0 0 0 0 0 0 0 -1
Taxation 0 0 0 0 -1 0 0 0 -2 -2
Exceptional Items
PAT 0 0 0 1 1 1 0 1 4 7
Adjusted EPS 4 2 0 1 1 1 0 1 4 6

Vaishali Pharma Ltd. Cash Flow

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 4 -7 -4 5 0 -9 4 3 2 1
Cash Fr. Inv. 0 0 2 3 1 1 0 0 0 -1
Cash Fr. Finan. -4 6 2 -8 -1 9 -4 -3 -2 0
Net Change 0 -1 0 0 0 0 0 0 1
Cash & Cash Eqvt 2 1 1 1 0 0 0 0 0 1

Vaishali Pharma Ltd. Shareholding Pattern

9 Qtrs 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%)
Promoter 63.81 59.21 56.31 56.31 26.74 26.74 26.74 26.74 26.74
Public 36.19 40.80 43.69 43.69 73.25 73.26 73.26 73.24 73.26
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Vaishali Pharma Ltd. Announcements

Tue, 06 Jun 2023
Clarification - Financial Results
The Exchange has sought clarification from Vaishali Pharma Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Mon, 05 Jun 2023
Clarification - Financial Results
The Exchange has sought clarification from Vaishali Pharma Limited for the quarter ended 31-Mar-2023 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company is required to clarify the following: -1. The company has not submitted the Statement of Modified Opinion or in case of unmodified opinion(s), a declaration to that effect to the Stock Exchange. The response of the Company is awaited.
Wed, 31 May 2023
Annual Secretarial Compliance Report
ANNUAL SECRETARIAL COMPLIANCE REPORT OF VAISHALI PHARMA LIMITEDFOR THE YEAR ENDED MARCH 31, 2023

Vaishali Pharma Ltd. Technical Scans

Thu, 08 Jun 2023
Opening at High Opening at High
High Decrease in 1 Month High Decrease in 1 Month
High Decrease in 3 Months High Decrease in 3 Months
High Increase in 1 Year High Increase in 1 Year
High Increase in 2 Years High Increase in 2 Years

Vaishali Pharma Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 236,838.35 987.10 -2.7%
Divi's Laboratories Ltd. 92,904.71 3,499.65 -1.2%
Cipla Ltd. 77,933.48 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. 77,441.55 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. 70,842.70 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. 60,989.56 1,802.05 +0.0%
Mankind Pharma Ltd. 58,646.15 1,464.00 -1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 27.95 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 50.95 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 27.81 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 17.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 86.49 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 48.99 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 45.75 1,464.00 -1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 4.23 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2023-03 7.28 3,499.65 -1.2%
Cipla Ltd. Consolidated 2023-03 3.33 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 3.33 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 11.45 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9.84 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2023-03 4.99 1,464.00 -1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 0.04 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 0.14 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 13.10 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 26.72 1,464.00 -1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 21,763.34 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 7,781.56 1,464.00 -1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 987.10 -2.7%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,499.65 -1.2%
Cipla Ltd. Consolidated 2022-03 2,559.47 965.45 +0.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,649.90 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,927.00 -2.0%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,802.05 +0.0%
Mankind Pharma Ltd. Consolidated 2022-03 1,452.96 1,464.00 -1.5%

Vaishali Pharma Ltd. FAQ's

What is Vaishali Pharma share price?

Can I buy Vaishali Pharma shares now?

What is the Market Cap of Vaishali Pharma?

What are the key metrics to analyse Vaishali Pharma?

What is the 52 Week High and Low of Vaishali Pharma?

What is the trend of Vaishali Pharma share price?